Enhancing Oncology Model (EOM) White Paper: Perspectives from Oncology Practices and the Path Forward in Value-Based Care
Enhancing Oncology Model (EOM) White Paper: Perspectives from Oncology Practices and the Path Forward in Value-Based Care
Enhancing Oncology Model (EOM) White Paper:
Perspectives from Oncology Practices and the Path Forward in Value-Based Care
The Enhancing Oncology Model (EOM) marks the next chapter in value-based care for oncology, building on the Oncology Care Model (OCM) with a new framework for risk-based reimbursement. This white paper offers insights into the EOM’s design, challenges, and opportunities for oncology practices, payers, and pharmaceutical manufacturers.
Key takeaways include:
- How EOM differs from OCM, introducing mandatory downside risk, lower payments, and a focus on health equity
- Opportunities for oncology practices, leveraging OCM learnings to deliver high-quality care while navigating new requirements
- Implications for pharmaceutical manufacturers, with guidance on pricing, value messaging, and support for healthcare providers
- Strategies for improving patient outcomes, focusing on coordinated care, health equity, and social determinants of health
Download the white paper to explore actionable strategies and insights to adapt to this transformative model in oncology care.
